Immune Microenvironment in Glioblastoma Subtypes.

Area of Science:

• Neuro-oncology
• Cancer immunology

Background:

• Glioblastomas (GBMs) are aggressive primary brain tumors with poor prognoses.
• GBMs exhibit significant molecular and histological heterogeneity, complicating treatment.
• Tumor-associated macrophages (TAMs) are key non-neoplastic cells within the GBM microenvironment.

Purpose of the Study:

• To review the origin, features, and functions of TAMs in distinct glioblastoma subtypes.
• To explore TAM interactions with other immune cells in the GBM microenvironment.
• To discuss therapeutic strategies targeting TAMs for enhanced glioblastoma treatment.

Main Methods:

• Literature review of correlative and experimental data.
• Analysis of GBM subtypes and their associated microenvironments.
• Examination of TAM roles in glioblastoma pathogenesis.

Main Results:

• Distinct GBM subtypes are associated with unique microenvironmental characteristics, including TAM populations.
• Genetic driver mutations in GBM can influence the tumor microenvironment and TAM behavior.
• TAMs play a critical role in modulating the GBM immune landscape.

Conclusions:

• Understanding TAM heterogeneity in GBM subtypes is crucial for developing effective therapies.
• Targeting TAMs holds promise for overcoming therapeutic resistance in glioblastoma.
• Modulating TAMs may enhance the efficacy of T-cell-based immunotherapies for glioblastoma.